Udvalget for Veterinærlægemidler (CVMP) fandt, at fordelene ved Quadrisol, i form af reduktion af inflammation og lindring af smerter forårsaget af muskuloskeletale sygdomme og skader, opvejer eventuelle risici.
The Committee for Medicinal Products for Veterinary Use (CVMP) agreed that the benefits of Quadrisol to reduce of inflammation and relieve pain caused by musculoskeletal disorders and trauma are greater than any risks associated with this treatment.